Cvs Health (CVS) Operating Leases (2019 - 2026)

Cvs Health's Operating Leases history runs 8 years deep, the most recent figure standing at $13.3 billion for Q1 2026.

• Quarterly Operating Leases fell 8.66% year-over-year to $13.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 billion (down 8.66% YoY) and the FY2025 annual result came in at $13.6 billion, down 8.43% from the prior year.
• Operating Leases was $13.3 billion for Q1 2026 at Cvs Health, down from $13.6 billion in the prior quarter.
• Across five years, Operating Leases topped out at $17.8 billion in Q1 2022 and bottomed at $13.3 billion in Q1 2026.
• A 5-year average of $15.7 billion and a median of $15.7 billion in 2024 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2023 — Operating Leases slipped 4.27% — and 2026, when it declined 8.66%.
• Cvs Health's Operating Leases stood at $16.8 billion in 2022, then fell by 4.56% to $16.0 billion in 2023, then retreated by 7.08% to $14.9 billion in 2024, then retreated by 8.43% to $13.6 billion in 2025, then dropped by 2.29% to $13.3 billion in 2026.
• Business Quant data shows CVS's Operating Leases at $13.3 billion in Q1 2026, $13.6 billion in Q4 2025, and $14.0 billion in Q3 2025.